Zenotech Laboratories Limited
ZENOTECH
Rank in Stocks
#25461
Zenotech Laboratories Ltd. is a pharmaceutical company specializing in the... Zenotech Laboratories Ltd. is a pharmaceutical company specializing in the development, manufacturing, and commercialization of various medical products. Notably, its production activities include granulocyte-colony stimulating factor (GCSF) and granulocyte-macrophage colony-stimulating factor (GMCSF). The company's range of injectable offerings is strategically targeted at niche therapeutic areas such as oncology (cancer treatment) and anesthesiology. Founded on June 15, 1989, Zenotech Laboratories Ltd. maintains its headquarters in Hyderabad, India.
Share Price
$0.41480163
Last synced: 2026-11-13
Market Cap
$25.32M
Change (1 day)
-1.56%
Change (1 year)
-26.86%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Zenotech Laboratories Limited (ZENOTECH)
Category
Healthcare
EPS for Zenotech Laboratories Limited (ZENOTECH)
EPS as of September 2026 TTM: $-0.01
According to Zenotech Laboratories Limited's latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2025 the company had an EPS of $0.01, a decrease compared to its 2024 EPS of $0.02.
EPS history for Zenotech Laboratories Limited from 2006 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.01 | -173.00% |
| 2025 | $0.01 | -33.74% |
| 2024 | $0.02 | -29.44% |
| 2023 | $0.02 | -51.67% |
| 2022 | $0.05 | -1,870.37% |
| 2021 | 0.00 | -111.49% |
| 2020 | $0.02 | -421.92% |
| 2019 | $-0.01 | -78.78% |
| 2018 | $-0.03 | -59.29% |
| 2017 | $-0.08 | 6.02% |
| 2016 | $-0.08 | -40.66% |
| 2015 | $-0.13 | 27.78% |
| 2014 | $-0.11 | -18.90% |
| 2013 | $-0.13 | 132.26% |
| 2012 | $-0.06 | -76.15% |
| 2011 | $-0.23 | 206.28% |
| 2010 | $-0.08 | -19.83% |
| 2009 | $-0.10 | -23.08% |
| 2008 | $-0.12 | -1,060.47% |
| 2007 | $0.01 | -135.44% |
| 2006 | $-0.04 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $1.69 | -23,250.68% |
US
|
|
| $1.90 | -26,110.96% |
SE
|
|
| $6.83 | -93,724.66% |
FR
|
|
| $0.02 | -367.12% |
HK
|
|
| $2.81 | -38,606.85% |
IT
|
Questions about Zenotech Laboratories Limited's earnings per share (EPS)
What is Zenotech Laboratories Limited's earnings per share (EPS)?
Zenotech Laboratories Limited's earnings per share (EPS) over the last twelve months is $-0.01, as of Sep 2026.
What was Zenotech Laboratories Limited's earnings per share (EPS) in 2025?
In 2025, Zenotech Laboratories Limited's earnings per share (EPS) was $0.01, 50.00% less than in 2024 ($0.02).
How has Zenotech Laboratories Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Zenotech Laboratories Limited's earnings per share (EPS) went from $0.02 to $0.01, an average decline of 12.94% a year.
How does Zenotech Laboratories Limited's earnings per share (EPS) compare with similar companies?
Zenotech Laboratories Limited's earnings per share (EPS) ($-0.01) is lower than that of all 5 similar companies listed above. The highest among them is Ipsen S.A., with $6.83.